CLOROX CO /DE/ reported revenue of $1.95B for the period ended 2026-06-30, -2.0% year on year. Net income was $0.16B, a 8.4% net margin on a 41.3% gross margin. Free cash flow for the period was $0.24B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.95B | -2.0% |
| Gross profit | $0.80B | — |
| Operating income | $0.25B | — |
| Net income | $0.16B | -50.9% |
| Gross margin | 41.3% | Net margin 8.4% |
| Revenue Q/Q | +16.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $1.14B | 58.7% |
| R&D | $0.03B | 1.6% |
| SG&A | $0.51B | 26.4% |
| Tax & other | $0.08B | 4.3% |
| Item | Amount |
|---|---|
| Total assets | $6.44B |
| Total liabilities | $6.34B |
| Shareholders' equity | $0.09B |
| Equity / assets | 1.4% |
| Operating cash flow | $0.33B |
| Capital expenditure | $0.09B |
| Free cash flow | $0.24B |
| Cash conversion (OCF / net income) | 202% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CME ・ CMS ・ KO ・ CTSH ・ COHR ・ COIN ・ CL ・ CMCSA ・ FIX ・ COP ・ ED ・ STZ
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies